SCHEMBL4445299

SCHEMBL4445299

CC(C)Oc1cc(C2C(C)OC(=O)N2C)ccc1-c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
HPGD P15428 2/20 0.39
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
POLB P06746 2/20 0.37
HIF1A Q16665 2/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
PTGS1 P23219 1/20 0.37
SLC6A2 P23975 1/20 0.37
MAPK1 P28482 1/20 0.37
STAT1 P42224 1/20 0.37
CASP3 P42574 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445385 0.87 PGR (0.40) ALDH1A1HPGDMAPTSMN1; SMN2KMT2A
SCHEMBL4460630 0.84 GRM2 (0.41) ALDH1A1HPGDMAPTSMN1; SMN2KMT2A
SCHEMBL4472192 0.83 GRM2 (0.35) MDM2
SCHEMBL4454827 0.82 ESR2 (0.39) KMT2AMEN1HSD17B10HSD17B2
SCHEMBL4458127 0.81 GRM2 (0.38) HPGDMAPTKMT2AMEN1HIF1A
SCHEMBL4447352 0.81 GRM2 (0.37) ALDH1A1KMT2AMEN1HSD17B10MDM2
SCHEMBL4453552 0.80 BRD4 (0.35) ALDH1A1HPGDMAPTSMN1; SMN2POLB
SCHEMBL4469790 0.80 PTGDR2 (0.35) ALDH1A1HPGDSMN1; SMN2KMT2AMEN1
SCHEMBL4474719 0.78 PDE3B (0.39)
SCHEMBL4445293 0.75 ALDH1A1 (0.42) ALDH1A1HPGDMAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 ALDH1A1 150/4885HPGD 137/4885MAPT 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.